VF
VOR icon

Virtu Financial’s Vor Biopharma VOR Stock Holding History

Virtu Financial’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,104
Closed -$395K – 2285
2025
Q3 		$395K Sell
8,104
-5,692
-41% -$229K 0.02% 647
2025
Q2 		$447K Buy
+13,796
New +$122K 0.02% 613
2025
Q1 		– Sell
-2,724
Closed -$60K – 2087
2024
Q4 		$60K Buy
+2,724
New +$45.1K ﹤0.01% 1127
2024
Q3 		– Sell
-619
Closed -$12K – 1928
2024
Q2 		$12K Buy
+619
New +$20K ﹤0.01% 1112
2023
Q3 		– Sell
-588
Closed -$36K – 1940
2023
Q2 		$36K Sell
588
-190
-24% -$17.4K ﹤0.01% 1176
2023
Q1 		$84K Buy
+778
New +$86.2K 0.01% 1017
2022
Q3 		– Sell
-613
Closed -$61K – 2272
2022
Q2 		$61K Buy
+613
New +$62.7K 0.01% 1069

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Virtu Financial's VOR Position: Q4 2025 in Review

Virtu Financial sold out of Vor Biopharma (VOR) in Q4 2025, closing a stake of 8,104 shares — an estimated $395K sold.

Virtu Financial first reported a position in VOR in Q2 2022 and held it in 7 quarters. The position peaked at $447K in Q2 2025. 55 funds tracked by Wall St. Rank hold VOR as of Q4 2025.

  • Virtu Financial reported no remaining Vor Biopharma position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 8,104 Vor Biopharma shares in Q4 2025, an estimated $395K.
  • Virtu Financial first reported a position in Vor Biopharma in Q2 2022 and held it in 7 quarters.
  • Virtu Financial's Vor Biopharma position peaked at $447K in Q2 2025.
  • 55 funds tracked by Wall St. Rank held Vor Biopharma as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.